Summary of Amendments to last Edition

New

• Advice on use of COX-II inhibitors
  

• Advice on use of venlafaxine
  

• Section on sleep hygiene
  

• Section 4.4. CNS stimulants & drugs used for ADHD
  

• Section 5. Advice on the treatment of GU infections
  

• Advice on therapeutic drug monitoring of antibiotics
  

• Sections 7.1 & 7.2
  

• Guideline for use of acetylcysteine to prevent contrast-induced nephropathy
  

• Guideline for doxycycline pleurodesis
  

• Phenytoin filtration guideline
  

• Palliative care symptom control guidelines

Updated

• Rabeprazole suggested as PPI of choice with warfarin
  

• IV omeprazole - indications for prescribing
  

• Statin prescribing
  

• Depression guidance
  

• Guidelines for prescribing 'z' drugs
  

• Management of acute aggression
  

• Costs of PPIs, antidepressants & NSAIDs (Sections 1.3, 4.3 & 10.1)
  

• Advice on prescribing co-proxamol
  

• Preferred choice of bisphosphonate
  

• Recommendations for use of amphoteracin B preparations
  

• Management of MRSA infection
  

• Treatment of skin and soft tissue infections

Medicine Additions

• Adalimumab
  

• Buprenorphine patches
  

• Epaderm
  

• Eplerenone
  

• Hydromol
  

• Insulin detemir
  

• Iron dextran (Cosmofer)
  

• Olsalazine
  

• Omacor
  

• Pregabalin
  

• Paracetamol IV
  

• Rosuvastatin
  

• Strontium ranelate
  

• Teriparatide

Medicine Deletions

• Dicycloverine tablets
  

• Femoston 2/20 tablets
  

• Propantheline tablets
  

• Pyridostigmine injection
  

• Rofecoxib tablets
  

• Theophylline liquid

12 June 2005